Advertisment Fosfocin
Indian Journal of Critical Care Medicine
An open access publication of ISCCM™ 
Users online: 1655 
     Home | Login 
  About Current Issue Archive Search Instructions Online Submission Subscribe Etcetera Contact  
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded126    
    Comments [Add]    

Recommend this journal


Year : 2017  |  Volume : 21  |  Issue : 3  |  Page : 138--145

Early prediction of 3-month survival of patients in refractory cardiogenic shock and cardiac arrest on extracorporeal life support

1 Intensive Care Unit, Department of Anesthesia and Critical Care, University Hospital of Toulouse, Toulouse; Department of Cardiology, University Hospital of Rangueil, Toulouse, France
2 Intensive Care Unit, Department of Anesthesia and Critical Care, University Hospital of Toulouse, Toulouse, France
3 Department of Cardiology, University Hospital of Rangueil, Toulouse, France
4 Department of Cardiovascular Surgery, University Hospital of Rangueil, Toulouse, France

Correspondence Address:
Dr. Clément Delmas
Intensive care Unit, University Hospital of Toulouse - Rangueil, 1 Avenue Jean Poulhes 31059 Toulouse Cedex
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijccm.IJCCM_32_17

Rights and Permissions

Background: Extracorporeal life support (ECLS) holds the promise of significant improvement of the survival of patient in refractory cardiogenic shock (CS) or cardiac arrest (CA). Nevertheless, it remains to be shown to which extent these highly invasive supportive techniques could improve long-term patient's outcome. Methods: The outcomes of 82 adult ECLS patients at our institution between January 2012 and December 2013 were retrospectively analyzed. Results: Patients were essentially men (64.7%) and are 54 years old. Preexisting ischemic (53.7%) and dilated cardiomyopathy (14.6%) were frequent. ECLS indications were shared equally between CA and CS. ECLS-specific adverse effects as hemorrhage (30%) and infection (50%) were frequent. ECLS was effective for 43 patients (54%) with recovery for 35 (43%), 5 (6%) heart transplant, and 3 (4%) left ventricular assist device support. Mortality rate at 30 days was 59.8%, but long-term and 3-month survival rates were similar of 31.7%. Initial plasma lactate levels >5.3 mmol/L and glomerular filtration rate <43 ml/min/1.73 m2 were significantly associated with 3-month mortality (risk ratio [RR] 2.58 [1.21–5.48]; P = 0.014; RR 2.10 [1.1–4]; P = 0.024, respectively). Long-term follow-up had shown patients paucisymptomatic (64% New York Heart Association 1–2) and autonomic (activities of daily living [ADL] score 6 ± 1.5). Conclusion: In case of refractory CA or CS, lactates and renal function at ECLS initiation could serve as outcome predictor for risk stratification and ECLS indication.


Print this article     Email this article

Online since 7th April '04
Published by Wolters Kluwer - Medknow